BridgeMD
Tests treatment safety and results for Tinnitus, Subjective
Official title Efficacy of Walking Exercise With Dog on Tinnitus Complaints in Sleep Apnea (Obstructive Sleep Apnea)
ClinicalTrials.gov ID: NCT06803095
What this study is testing
- What it's testing
- there is evidence that tinnitus (chronic subjective form) is highly prevalent among patients with obstructive sleep apnea. exercise is recommneded in chronic subjective form) and obstructive sleep apnea.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 45
You may be able to join if
- obese persons
- bilateral chronic subjective tinnitus
- mild obstructive sleep apnea (mild apnea hypopnea index)
- forty participants
You likely can't join if
- body mass index more than 40 kg/m2.
- cardiovascular problems
- hepatorenal probelms
- autoimmune problems
- orthopedic probelms
The study team makes the final eligibility decision.
Where it's taking place
- Dokki, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dokki, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.